Atherogenic effect of systemic lupus erythematosus pts blood serum
Objective. To study relation of SLE pts blood serum atherogenicity to disease activity and corticosteroids (CS) administration. Methods. 40 young women with SLE were included. 20 of them did not received CS (group 1) and 20 were treated with small doses of CS (<15 mg/day) for a long time (gro...
Main Authors: | Z S Alekberova, E V Gerasimova, I A Sobenin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2003-06-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1218 |
Similar Items
-
Ovarial function in pts with systemic lupus erythematosus
by: S Sh Sliabanova, et al.
Published: (2004-06-01) -
Metabolic syndrome in patients with systemic lupus erythematosus
by: T Y Popkova, et al.
Published: (2008-08-01) -
Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
by: T A Panafidina, et al.
Published: (2008-05-01) -
Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
by: Zahra Rezaieyazdi, et al.
Published: (2022-01-01) -
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
by: T V Popkova, et al.
Published: (2008-05-01)